1 rich Libsyn https://www.libsyn.com 90 600 In this week’s View, Dr. Eagle&amp;nbsp;highlights several trials&amp;nbsp;recently&amp;nbsp;presented at&amp;nbsp;the&amp;nbsp;TCT Conference in San Francisco.&amp;nbsp;The&amp;nbsp;SELUTION&amp;nbsp;DeNovo&amp;nbsp;trial found that use of the sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine&amp;nbsp;drug-eluting stent&amp;nbsp;implantation in patients with&amp;nbsp;de novo&amp;nbsp;coronary artery disease.&amp;nbsp;In the ANDES trial, results showed that&amp;nbsp;the&amp;nbsp;use of direct oral anticoagulants&amp;nbsp;after&amp;nbsp;left&amp;nbsp;atrial appendage closure&amp;nbsp;in&amp;nbsp;patients with&amp;nbsp;non-valvular&amp;nbsp;atrial fibrillation&amp;nbsp;was not superior to&amp;nbsp;dual antiplatelet therapy&amp;nbsp;in preventing device-related thrombosis.&amp;nbsp;Finally, Dr. Eagle discusses&amp;nbsp;the PROCTOR study&amp;nbsp;in which&amp;nbsp;percutaneous coronary intervention (PCI) on&amp;nbsp;saphenous vein grafts&amp;nbsp;versus&amp;nbsp;native&amp;nbsp;vessel PCI in&amp;nbsp;post-coronary artery bypass grafting in&amp;nbsp;patients presenting&amp;nbsp;with&amp;nbsp;graft failure.&amp;nbsp; &amp;nbsp; Subscribe to Eagle’s Eye View&amp;nbsp;&amp;nbsp; &amp;nbsp; Eagle's Eye View: Your Weekly CV Update From ACC.org http://www.acc.org <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/38913980/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/195120060